PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Aditya Bardia, MD, MPH - Keeping to Target in mTNBC: Optimising Outcomes With Antibody-Drug Conjugates in Practice
Visit https://www.peervoice.com/WQS860 to view the entire programme with slides. After completing “Aditya Bardia, MD, MPH - Keeping to Target in mTNBC: Optimising Outcomes With Antibody-Drug Conjugates in Practice”, participants will be able to: Recognise the toxicity profile of antibody-drug conjugates (ADCs) for metastatic triple-negative breast cancer (mTNBC) and when they are most likely to occur; Propose practical approaches to mitigating and/or managing the toxicity profile of ADCs in patients with mTNBC; and Discuss the importance of an effective multidisciplinary team and patient communication and collaboration in treatment optimisation for patients with mTNBC who are receiving an ADC.